We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline... Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes pepinemab (VX15), which targets Huntington's Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others. Show more
Expect Topline Data for Phase 1/2a Randomized SIGNAL-AD Study of Pepinemab for Alzheimer’s Disease in Q3 2024 Company raised $17.9 million of new financing during Q4 2023 and Q1 2024 ROCHESTER...
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
Eight new antibody discovery agreements incorporate Vaccinex’s powerful ActivMAb® Drug Discovery Platform ActivMab® platform enables the discovery and development of high value antibodies against...
ROCHESTER, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.3011 | 28.101511879 | 4.63 | 5.95 | 4.5 | 6667 | 5.18921631 | CS |
4 | -1.4589 | -19.7415426252 | 7.39 | 7.59 | 4.432 | 10371 | 5.90786336 | CS |
12 | -2.4689 | -29.3916666667 | 8.4 | 13.02 | 4.432 | 65637 | 9.9786091 | CS |
26 | -8.0689 | -57.635 | 14 | 15.9096 | 4.432 | 74414 | 10.31579196 | CS |
52 | -75.9689 | -92.7581196581 | 81.9 | 100.8 | 4.432 | 279711 | 29.91348308 | CS |
156 | -510.6689 | -98.851897019 | 516.6 | 688.8 | 4.432 | 328127 | 222.52108334 | CS |
260 | -1409.4689 | -99.5809594461 | 1415.4 | 2568.3 | 4.432 | 587269 | 694.6318672 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions